LABORATORY RESEARCH β4 Integrin Signaling Induces Expansion of Prostate Tumor Progenitors Researchers found that a significant fraction of advanced human prostate cancers and castration-resistant metastases express high levels of the β4 integrin, which binds to laminin-5. [J Clin Invest] Full Article Shrinkage of Experimental Benign Prostatic Hyperplasia and Reduction of Prostatic Cell Volume by a Gastrin-Releasing Peptide Antagonist Scientists evaluated the effects of gastrin releasing-peptide antagonist RC-3940-II on viability and cell volume of benign prostatic hyperplasia (BPH)-1 human prostate epithelial cells and WPMY-1 prostate stromal cells in vitro, and in testosterone-induced BPH in Wistar rats in vivo. [Proc Natl Acad Sci USA] Abstract Inhibition of Protein Kinase CK2 Reduces CYP24A1 Expression and Enhances 1,25-Dihydroxyvitamin D3 Anti-Tumor Activity in Human Prostate Cancer Cells In order to isolate regulators of CYP24A1 expression in prostate cancer cells, the authors established a stable prostate cancer cell line PC3 with the CYP24A1 promoter driving luciferase expression to screen a small molecular library for compounds that inhibit CYP24A1 promoter activity. [Cancer Res] Abstract Valproic Acid Inhibits the Proliferation of Cancer Cells by Re-Expressing Cyclin D2 Primary murine prostate cancer (PCa) cells were derived using the well-established TRAMP model (transgenic adenocarcinoma mouse prostate). These PCa cells were treated with the histone deacetylase inhibitor, valproic acid (VPA), and researchers demonstrated that VPA treatment has an anti-migrative, anti-invasive and anti-proliferative effect on PCa cells. [Carcinogenesis] Abstract N-Cadherin Dependent Collective Cell Invasion of Prostate Cancer Cells Is Regulated by the N-Terminus of α-Catenin Using a cell line from bone metastasis of prostate cancer (PC3), researchers analyzed how prostate cancer cells migrate in a physiologically relevant 3D Matrigel. They found that PC3 cells migrated more efficiently as multi-cellular clusters than isolated single cells, suggesting that the presence of cell-cell adhesion improves 3D cell migration. [PLoS One] Full Article Expression of Osteoprotegerin from a Replicating Adenovirus Inhibits the Progression of Prostate Cancer Bone Metastases in a Murine Model Investigators hypothesized that a conditionally replicating adenoviruses armed with osteoprotegerin, an inhibitor of osteoclastogenesis, would inhibit the progression of prostate cancer bone metastases by directly lysing tumor cells and by reducing osteoclast activity. [Lab Invest] Abstract Apigenin Inhibits TGF-β-Induced VEGF Expression in Human Prostate Carcinoma Cells via a Smad2/3- and Src-Dependent Mechanism Low oxygen and transforming growth factor-β (TGF-β) are two major factors responsible for increased vascular endothelial growth factor (VEGF) secretion. Experiments were performed to investigate the inhibitory effect of apigenin on TGF-β-induced VEGF production and the mechanisms underlying this action. [Mol Carcinog] Abstract CLINICAL RESEARCH Extended vs. Standard Lymph Node Dissection in Robot-Assisted Radical Prostatectomy for Intermediate- or High-Risk Prostate Cancer: A Propensity-Score-Matching Analysis To overcome the limitation of retrospective analysis, researchers matched preoperative variables using propensity scores and compared the outcomes between patients treated with robot-assisted extended lymph node dissection and standard lymph node dissection. [BJU Int] Abstract Salvage Radical Prostatectomy as Management of Locally Recurrent Prostate Cancer: Outcomes and Complications Management of prostate cancer following radiation therapy remains challenging, especially for younger men or those with life expectancy greater than ten years. The authors outline the efficacy, safety and adequacy of radical prostatectomy for the treatment of radiorecurrent localized prostate cancer. [World J Urol] Abstract |